Gilead Sciences | Actif À Court Terme


Current Assets Changement
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
ALKERMES ALKS:US 1.05B 31.16M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Amgen AMGN:US $ 19322M 802M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Bristol Myers Squibb BMY:US $ 30186M 65M
Coherus Biosciences CHRS:US $ 446.78M 65.66M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Glaxosmithkline GSK:US $ 54188M 25200M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
Moderna Inc MRNA:US 13.56B 2.79B
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Ptc Therapeutics PTCT:US $ 694.68M 79.33M
Puma Biotechnology PBYI:US $ 114.28M 3.29M
Regeneron Pharmaceuticals REGN:US $ 15529.9M 1223.9M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
United Therapeutics UTHR:US $ 2684.3M 97.7M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M
YTE INCY:US $ 3625.84M 337.75M



Gilead Sciences Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.